126 related articles for article (PubMed ID: 11598459)
21. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
Oh KS; Lee S; Lee BH
Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
[TBL] [Abstract][Full Text] [Related]
22. Effects of pH, salt and time on ligand binding properties of overexpressed melanocortin 4 receptor.
Dolby V; Lundqvist A; Fröberg T; Lüllau E; Shaw J; Tjerneld F; Cronet P
J Biochem Biophys Methods; 2004 Mar; 58(3):195-205. PubMed ID: 15026206
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence polarization immunoassays and related methods for simple, high-throughput screening of small molecules.
Smith DS; Eremin SA
Anal Bioanal Chem; 2008 Jul; 391(5):1499-507. PubMed ID: 18264817
[TBL] [Abstract][Full Text] [Related]
24. Glutamine235 and arginine272 in human melanocortin 5 receptor determines its low affinity to MSH.
Frändberg PA; Xu X; Chhajlani V
Biochem Biophys Res Commun; 1997 Jul; 236(2):489-92. PubMed ID: 9240466
[TBL] [Abstract][Full Text] [Related]
25. Miniaturization of fluorescence polarization receptor-binding assays using CyDye-labeled ligands.
Harris A; Cox S; Burns D; Norey C
J Biomol Screen; 2003 Aug; 8(4):410-20. PubMed ID: 14567793
[TBL] [Abstract][Full Text] [Related]
26. Use of Fluorescence Indicators in Receptor Ligands.
Harikumar KG; Miller LJ
Methods Mol Biol; 2015; 1335():115-30. PubMed ID: 26260598
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of a high-affinity fluorescent PPARgamma ligand for high-throughput fluorescence polarization assays.
DeGrazia MJ; Thompson J; Heuvel JP; Peterson BR
Bioorg Med Chem; 2003 Oct; 11(20):4325-32. PubMed ID: 13129568
[TBL] [Abstract][Full Text] [Related]
28. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
[TBL] [Abstract][Full Text] [Related]
29. Characterization of ligand binding to melanocortin 4 receptors using fluorescent peptides with improved kinetic properties.
Link R; Veiksina S; Rinken A; Kopanchuk S
Eur J Pharmacol; 2017 Mar; 799():58-66. PubMed ID: 28132916
[TBL] [Abstract][Full Text] [Related]
30. [Identification of ligands for human LOX-1 through fluorescence polarization-based high throughput screening].
Zhang TT; Huang ZT; Dai Y; Liu AL; Zhu P; Du GH
Yao Xue Xue Bao; 2005 Sep; 40(9):792-5. PubMed ID: 16342678
[TBL] [Abstract][Full Text] [Related]
31. Single-molecule detection technologies in miniaturized high throughput screening: binding assays for g protein-coupled receptors using fluorescence intensity distribution analysis and fluorescence anisotropy.
Rüdiger M; Haupts U; Moore KJ; Pope AJ
J Biomol Screen; 2001 Feb; 6(1):29-37. PubMed ID: 11679163
[TBL] [Abstract][Full Text] [Related]
32. Characterization of melanocortin receptors.
Goetz AS; Ignar DM
Curr Protoc Pharmacol; 2003 Nov; Chapter 1():Unit1.28. PubMed ID: 21956799
[TBL] [Abstract][Full Text] [Related]
33. Identification of a melanocortin receptor expressed by murine brain microvascular endothelial cells in culture.
de Angelis E; Sahm UG; Ahmed AR; Olivier GW; Notarianni LJ; Branch SK; Moss SH; Pouton CW
Microvasc Res; 1995 Jul; 50(1):25-34. PubMed ID: 7476577
[TBL] [Abstract][Full Text] [Related]
34. Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer.
Owicki JC
J Biomol Screen; 2000 Oct; 5(5):297-306. PubMed ID: 11080688
[TBL] [Abstract][Full Text] [Related]
35. Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions.
Handl HL; Vagner J; Yamamura HI; Hruby VJ; Gillies RJ
Anal Biochem; 2004 Jul; 330(2):242-50. PubMed ID: 15203329
[TBL] [Abstract][Full Text] [Related]
36. High throughput fluorescence polarization: a homogeneous alternative to radioligand binding for cell surface receptors.
Allen M; Reeves J; Mellor G
J Biomol Screen; 2000 Apr; 5(2):63-9. PubMed ID: 10803605
[TBL] [Abstract][Full Text] [Related]
37. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
[TBL] [Abstract][Full Text] [Related]
38. Cell-free assay of G-protein-coupled receptors using fluorescence polarization.
Jones JW; Greene TA; Grygon CA; Doranz BJ; Brown MP
J Biomol Screen; 2008 Jun; 13(5):424-9. PubMed ID: 18567842
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Agouti-related protein binding to melanocortin receptors.
Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
[TBL] [Abstract][Full Text] [Related]
40. Use of scintillation proximity assay to measure radioligand binding to immobilized receptors without separation of bound from free ligand.
Berry J; Price-Jones M; Killian B
Methods Mol Biol; 2012; 897():79-94. PubMed ID: 22674161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
